The daily pill Rezdiffra is the first treatment for people with a type of liver disease known as MASH, which affects up to 20% of people with type 2 diabetes.
Diabetes & Weight Loss News
77 readers recommended
The FDA has approved Wegovy (semaglutide) for reduction of major adverse cardiovascular events (MACE) in people with obesity and overweight and without diabetes, based...
35 readers recommended
In new studies presented at ATTD, CGM used with GLP-1s led to greater A1C reductions than GLP-1s alone.
36 readers recommended
The new Look AHEAD trial analysis shows major heart and kidney benefits for type 2 diabetes patients in remission, reshaping views on lifestyle changes.
63 readers recommended
Explore the crucial link between diabetes and accelerated age-related muscle loss (sarcopenia), its impact on health, and strategies for managing muscle health in people...
34 readers recommended
2024 brings insulin price cuts but analysis shows 775 med price hikes, including diabetes drugs. Future price negotiations and affordability resources highlighted
23 readers recommended
The FDA is investigating reports of suicidal thoughts or actions in people taking diabetes and weight loss medications like Ozempic, Wegovy, and Mounjaro. Research is...
27 readers recommended
Explore weight management in children with diabetes with expert tips on healthy eating, regular exercise, and avoiding restrictive diets for overall health.
30 readers recommended
LillyDirect, a new telehealth platform and online pharmacy, aims to improve access to resources and medication for people living with diabetes, obesity, and migraines.
33 readers recommended
Polycystic ovarian syndrome (PCOS) affects millions, elevating the risk of type 2 diabetes due to hormonal imbalances and insulin resistance. Learn about its genetic...
32 readers recommended
Discover diaTribe's best 2023 diabetes articles on new treatments, advances in technology, lifestyle tips, and groundbreaking insights for better diabetes management.
24 readers recommended
Explore the emerging effects of GLP-1 receptor agonists on glycemic control and weight management, including their potential impact on birth control pill absorption and...
155 readers recommended
This article details Mounjaro's efficacy in type 2 diabetes management, highlighting the drug’s ability to significantly reduce A1C and body weight. Read about the...
28 readers recommended
People with diabetes are at higher risk for health issues like chronic kidney disease, diabetic macular edema, and liver disease. Here are clinical trials studying ways...
25 readers recommended
Orforglipron, Eli Lilly's once-daily oral GLP-1 receptor agonist, is being studied in ongoing clinical trials for obesity and type 2 diabetes. Data shows A1C reductions...
32 readers recommended
Explore the comprehensive diabetes support available to U.S. veterans. Here we highlight VHA benefits, the impact of obesity and mental health on diabetes risk, and...
39 readers recommended
FDA approves Zepbound for obesity management alongside diet and exercise. A promising new option for weight control, it's the second once-weekly injectable after Wegovy...
47 readers recommended
Explore the VITAL-CGM trial, which investigates if using a combination of CGM and WeightWatchers can lower A1C in people with type 2 diabetes.
24 readers recommended
Explore the link between obesity, diabetes, and breast cancer risk. Learn how treatments like bariatric surgery and medications can reduce this risk and aid in diabetes...
23 readers recommended
In case you missed them, here are our top stories from October 2023 that cover upcoming therapies, groundbreaking research, and more.